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Considerable evidence now supports an active role for vascular endothelial
cells in the initiation of inflammatory and immunological responses, including
adhesion of circulating leukocytes, stimulation of intravascular coagulation, and
presentation of antigen to T cells . In previous studies (1-4), we have shown that
some of these endothelial effects can be induced in vitro by well-defined mon-
okines, lymphokines, and other stimuli . In particular, IL-1, tumor necrosis factor
(TNF), and bacterial LPS stimulate the synthesis and surface expression of a
tissue factor-like procoagulant activity in cultured human endothelial cells (1, 2)
and increase endothelial adhesivity for leukocytes (3, 4) . Similar results have
been reported by others (5, 6) . These inducible functions are dependent on
protein and RNA synthesis, are maximal 4-6 h afterexposure to the monokines,
and decline by 24 h (4) . We recently reported (7) that both IL-1 and TNF also
induce the expression of a new endothelial cell surface protein, identified
by specific binding to an mAb, H4/18, which had been developed by immuni-
zation with IL-1-treated endothelial cells . The time sequence of induction of the
H4/18 binding antigen and its susceptibility to metabolic inhibitors were similar
to those observed for increased procoagulant activity and leukocyte adhesion,
suggesting that 1-14/18 binding could be a useful marker for these inducible
endothelial functions .
Using immunocytochemical techniques, we now report that the H4/18 binding
antigen can be induced in microvascular endothelium of human skin in delayed
hypersensitivity reactions (DHR), and that it can be detected in a variety of
human inflammatory conditions with an immune background . These studies
indicate that H4/18 is a useful marker for activated endothelium in situ, and
lend credence to the relevance of inducible endothelial functions initially ob-
served in vitro, to inflammation in vivo .
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Materials and Methods
BriefDefinitive Report
mAbs and Immunohistochemical Techniques. mAb H4/18, developed by immunizing
BALB/c mice with cultured human umbilical vein endothelial cells (HEC) pretreated for
4 h with 5 U/ml of affinity-purified human IL-I, hasbeen described previously (7) . H4/18
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was detected by immunoperoxidase screening of binding to IL-1-treated vs . control HEC ;
the antibody is of the IgGIK isotype . For the present study, the antibody was used as the
culture supernatant, diluted in 10% horse serum to a concentration of ^-0.05 mg/ml of
mouse Ig . In some experiments, F(ab')2 fragments of antibody were prepared from ascites
fluid (8) and reconstituted to ^-3 .4 mg/ml .
For immunohistochemical studies, tissues were frozen in isopentane liquid nitrogen ; 4-
6 Am frozen sections were fixed in acetone for 10 min, washed three times in PBS, and
incubated for either 1 h at room temperature or occasionally overnight at 4°C with
optimally diluted mAbs . Sections were then washed and incubated with peroxidase-
conjugated rabbit anti-mouse IgG (Dako Corp ., Santa Barbara, CA), diluted in PBS
containing 20% normal human serum for 30-60 min . Peroxidase activity was detected
using either diaminobenzidine (DAB, 6 mg/ml in 0 .1 M Tris/saline buffer at pH 7.6 with
0 .03% H202), or acetylethylcarbazol (AEC, 0.02% in 5% dimethyl formamide, 0.2%
sodium acetate buffer, pH 5, with 0.03% H 20 2 ) containing reaction mixtures . The sections
were then washed in distilled water, lightly post-stained with hematoxylin, and mounted .
Control antibody was routinely tested on step sections of the same tissue specimens .
The control used was an irrelevant IgGIK supernatant, K16/16 . Six other control
antibodies prepared against rat renal structures, and having the same isotype and Ig
concentration, were tested on selected specimens . Step sections were also stained with
anti-von Willebrand factor (anti-vWF) mAb (Cappel Laboratories, Cochranville, PA) ;
these served as positive controls for normal endothelial staining.
Delayed Hypersensitivity Reactions .
￿
Two sets ofDHR were elicited on forearm skin of a
healthy male volunteer using streptococcal varidase (Lederle, The Netherlands, B.V . ;
containing 100,000 IU/ml of streptokinase and 25,000 IU/m) of streptodornase) as
antigen . In the first study, the streptococcal varidase reaction site, an area of erythema
and induration ^-35 mm inches in diameter, was biopsied under local anaesthesia at 23 h .
In the second study, a control punch biopsy was obtained, and immediately thereafter 0.1
ml of varidase was injected intracutaneously in two sites . At 16 h, both sites were strongly
reactive, with erythema and induration measuring 35 mm in diameter . One of the two
sites was biopsied at 16 h, and the second at 6 days, when the induration and erythema
had largely disappeared .
Tissues.
￿
A variety of normal and pathologic tissues (see Results) were selected from
fresh surgical specimens or from a bank of frozen tissue in the Department of Pathology
at the University of Leiden School of Medicine, The Netherlands, or at the Brigham and
Women's Hospital . In addition to the immunohistochemical studies, representative sec-
tions were stained with hematoxylin and eosin, and other special stains as required, and
most of the lymph nodes were subjected to immunophenotypic analysis of lymphoid cells,
using commercially available antisera (9) .
Results
Normal Tissues .
￿
There was no staining in H4/18 antibody in the microvas-
cular endothelium (arterioles, capillaries, and venules) of the following normal
tissues examined : skin (chest, arm, abdomen, neck) ; kidney ; heart ; skeletal
muscle ; liver ; spleen ; ovaries ; lung ; or subcutaneous fat . Four normal lymph
nodes were also negative . Onelymph node obtained from a lymph node dissection
for prostatic carcinoma showed fine specks of positive staining along the vascular
endothelium of postcapillary venules . In some skin sections, there was focal
staining of squamous epithelium and eccrine duct epithelium . When the same
tissues were stained with anti-vWF antibody, there was the expected strong
staining of normal endothelial cells . Attempts to increase the sensitivity of the
immunoperoxidase-labeling technique including the avidin-biotin procedure
(10), did not uncover endothelial staining in the normal tissues .
Delayed Hypersensitivity Reactions .
￿
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FIGURE 1 .
￿
Photomicrographs of serial frozen sections from skin biopsy 23 h after eliciting a
DHR. (A) Stained with hematoxylin and eosin, and (B) with immunoperoxidase technique
usingH4/18antibody . The peroxidase-positive outlines in B correspond to small vessels in the
deep mononuclear infiltrate in A (long arrows) . Arrowheads in B point to staining in the more
superficial dermal vessels. Original magnification, x 40.
FIGURE 2 . High magnification photomicrograph of positively staining vessel from same
section as in Fig . I B . Note that the staining is confined to the endothelium . Original
magnification, x 400 .
normal skin, the control punch biopsy showed no endothelial staining with the
mAb H4/18 . In contrast, the well-developed hypersensitivity reaction sites, at
16 and 23 h, exhibited strong reaction product in numerous small vessels in the
hypodermis and dermis (Fig . 1) . The staining outlined the vessel lumens, and on
high magnification (Fig . 2) appeared to be exclusively in endothelium; it was
most prominent in the deeper venules exhibiting a dense perivascular infiltrate,664
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FIGURE 3 .
￿
Hyperplastic vessel from a lymph node of a patient with angioimmunoblastic
lymphadenopathy and developing T cell lymphoma, stained for H4/18 binding antigen . The
staining is restricted to the lining endothelium . Original magnification, x 300 .
but was also present in the more superficial smaller vessels. The reaction product
wasgranular in both DAB-andin the AEC-reacted slides . Except for endogenous
peroxidase in polymorphonuclear leukocytes (present also in sections stained
with control antibodies), there was no staining of inflammatory cells either in
vessel lumina or in the perivascular infiltrate . The skin biopsy taken at 6 d
showed some foci of persistent perivascular inflammatory infiltrate, but there
was no staining with H4/18 in endothelium. Control antibodies failed to repro-
duce the endothelial staining obtained with H4/18. Anti-vWF antibody stained
microvascular endothelium in all sections at all time intervals .
Pathological Tissues .
￿
Our initial survey of pathological tissues with the H4/18
antibody has shown specific labeling of vascular endothelium in several clinico-
pathologic settings . There was extensive staining in a lymph node of a patient
with angioimmunoblastic lymphadenopathy with developing T cell lymphoma
(11) . The reaction product was exclusively in the endothelium (Fig . 3), most
prominently in the hyperplastic venules characteristic of this entity . There was
no staining of the highly pleomorphic mononuclear infiltrate within the lymph
node . No similar distribution of staining was seen with other mAbs used to
immunophenotype this patient's lymph node . The endothelium was also reactive
in lymph nodes of two cases of acute granulomatous lymphadenitis (consistent
with cat scratch disease) and in lymphocyte-rich thyroiditis (one case), hyperplastic
tonsillitis (three cases) ; and active inflammatory dermatitis (2 cases) . Endothelial
stainingwasalso observed in lymph nodes or skin of eight patients with Hodgkin's
orT cell lymphoma ; the staining was strongest in the hyperplastic vessels which
were often present in these conditions . In contrast, we have thus far found
minimal or no staining in lymph nodes with B cell lymphoma (four cases),
dermatopathic lymphadenitis (three cases), chronic sarcoid granuloma (three
cases), and in renal allograft rejection (eight cases), foreign-body granuloma (one
case), chronic pneumonitis (two cases), viral hepatitis (two cases), and around
burn wounds (three cases) . In two cases of appendicitis, endothelial staining was
noted in vessels surrounded by inflammatory infiltrate .
Discussion
In this study we have shown that the murine mAb H4/18, which binds an
antigen induced in cultured endothelium by IL-1, also recognizes an endothelialCOTRAN ET AL .
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molecule induced in vivo by DHR in human skin . The antigen can be also
detected by immunocytochemical techniques in pathological tissues mostly in
clinical settings of immunological activation . To our knowledge, this is the only
reported endothelial-specific mAb that fails to react with normal endothelium,
but identifies activated endothelium in vivo .
The immunohistochemical results reported here are consistent with the kinet-
ics of H4/18 binding in vitro . H4/18 uniformly fails to bind normal endothelial
cells, or normal and activated leukocytes in situ, as is the case in vitro . The IL-
1-induced binding in culture is transient ; in the induced DHR reactions in the
skin, H4/18 staining disappeared as the lesions faded . Our preliminary screening
of pathological tissue also suggests the antigen is transiently inducible by media-
tors . The staining was focal, andwas most prominent in hyperplastic endothelium
in settings of inflammatory or neoplastic reactions associated with activated
lymphocytes and macrophages .
Although evidence for the active role of the endothelial cell in inflammation
and the importance of inducible endothelium functions has come from recent
work, the notion of endothelial cell activation is a relatively old one. Early light
and electron microscopic studies of DHR described plump, hypertrophied en-
dothelium with increased numbers of intracellular organelles, and it was sug-
gested that the endothelium was activated in these reactions (12) . It now seems
likely that these changes of activation reflect some of the alterations in structure,
function, and growth induced in endothelium by specific lymphokines and
monokines . The studies reported here support the concept of endothelial acti-
vation and provide a useful marker for its further investigation in vivo .
Summary
We used a murine mAb, H4/18, raised by immunization with IL-1-treated
human umbilical vein endothelial cell cultures, to localize an endothelial activa-
tion antigen in induced human delayed hypersensitivity reactions (DHR) and in
pathological tissues . We used streptococcus varidase to elicitDHR in human skin
and we examined sequential skin biopsies with the immunoperoxidase technique .
There was no staining for H4/18 bindingantigen in normal endothelium of skin
and other tissues ; strong positive staining, localized to vascular endothelium, was
seen at 16 and 23 h but disappeared by 6 d, when the DHR had faded . H4/18
binding antigen, also confined to endothelium, was detected in lymph nodes,
skin, and other tissues exhibiting immune/inflammatory reactions . The studies
indicate that H4/18 is a useful marker for activated endothelium in vivo and
they support the relevance of in vitro studies on inducible endothelial cell
functions .
Most of the immunohistochemical studies reported here were performed in the Depart-
ment of Pathology, University of Leiden, The Netherlands . We thank the staff for
invaluable help and useful discussions, and particularly Dr . R . Willemze, Dr. P . Kluin, A .
Dijkstra, E . Dreef, and J . C . van Rijn .
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